| High EPO Dose May Increase Risk in Diabetic Dialysis Patients - Renal Business Today |
|
|
Renal Business Today BETHESDA, Md.—Higher doses of erythropoietin-stimulating agents (ESAs) may increase the risk of mortality and cardiovascular outcomes in diabetic dialysis patients, according to a study published online June 22 in Kidney International. |